You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
|
---|---|
Published in |
BMC Infectious Diseases, August 2014
|
DOI | 10.1186/1471-2334-14-465 |
Pubmed ID | |
Authors |
Jane Scott, Kathleen Rosa, Min Fu, Karin Cerri, Monika Peeters, Maria Beumont, Stefan Zeuzem, Donna M Evon, Leen Gilles |
Abstract |
Fatigue is a common symptom of chronic hepatitis C virus (HCV) infection and a frequent side-effect of peginterferon/ribavirin (PR) therapy for HCV. This study evaluated the impact of adding the oral HCV NS3/4A protease inhibitor simeprevir to PR on patient-reported fatigue and health status among patients with chronic HCV genotype 1 infection enrolled in the Phase IIb PILLAR and ASPIRE trials [NCT00882908; NCT00980330]. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Thailand | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 56 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 7 | 13% |
Other | 6 | 11% |
Student > Ph. D. Student | 6 | 11% |
Student > Bachelor | 5 | 9% |
Researcher | 5 | 9% |
Other | 11 | 20% |
Unknown | 16 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 39% |
Agricultural and Biological Sciences | 3 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Psychology | 2 | 4% |
Neuroscience | 2 | 4% |
Other | 7 | 13% |
Unknown | 18 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2017.
All research outputs
#5,681,022
of 22,919,505 outputs
Outputs from BMC Infectious Diseases
#1,697
of 7,696 outputs
Outputs of similar age
#54,542
of 236,681 outputs
Outputs of similar age from BMC Infectious Diseases
#28
of 158 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,696 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,681 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.